1-METHYL-3-(PYRAZIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE, 95.0%, 250mg

4-(AZETIDIN-3-YL)-2-METHYLPYRIMIDINE TRIFLUOROACETATE, 95.0%, 100mg

(1,3,5-Trimethyl-1H-pyrazol-4-yl)-methanol, 95.0%, 10g

4-(3-(BUT-3-EN-1-YLOXY)PHENYL)-2-CHLOROPYRIMIDINE, 95.0%, 250mg

2-Chloro-4-isopropoxybenzoic acid, 95+%, 500mg

5-Acetyl-2-(4-ethylphenoxy) pyridine, 95%, 250mg

2-Amino- N -(4-chloro-phenyl)-propionamide, 1g

4-CHLORO-6,7-DIETHOXYQUINAZOLINE, 95.0%, 100mg

6-Methoxy-1-methyl-1H-indole-3-carbaldehyde, 95.0%, 10g

Infinitely corrected plan PL 4x/0.10 IOS objective. Working distance 11.9 mm

2,3-Indoledione 3-Thiosemicarbazone, 2g

Methyl 6-Chloro-2-pyridinecarboxylate>98.0%(GC)5g

1-(3,5-Dimethyl-1H-pyrazole-4-sulfonyl)-piperidine, 95.0%, 250mg